Reaction

Injection Site Laceration reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 631 reports · 5 co-occurring drugs

As of the last recalculation, Injection Site Laceration appears in 631 FAERS reports alongside 5 co-occurring drug terms. The strongest observed disproportionality signal is EPINEPHRINE (PRR 37.6).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Epinephrine6737.637.7
Exenatide149.09.0
Galcanezumab-Gnlm88.58.5
Tirzepatide285.95.9
Evolocumab234.84.8

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.